Yutaro Yano

Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas

Yuji Ueda, Tsuyoshi Itoh, Ikuei Nukaya et al. · International Journal of Oncology · 2004 · 67 citations

Immunology, Pathology, Immunotherapeutics +22

Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients

Takeshi Kubota, Hitoshi Fujiwara, Y. Ueda et al. · British Journal of Cancer · 2002 · 37 citations · Full text

Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique

Kenichiro Imura, Yuji Ueda, Takashi Hayashi et al. · International Journal of Oncology · 2006 · 14 citations · Full text

Radiation Oncology, Cell Therapy, Cancer Vaccine Therapy +15

Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide

Kaori Okugawa, Tsuyoshi Itoh, Ichiro Kawashima et al. · Oncology Reports · 2004 · 10 citations

Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity

K Naito, Yuji Ueda, Tsuyoshi Itoh et al. · International Journal of Oncology · 2006 · 10 citations · Full text

Enhanced Antigen-presenting Capacity, Immunology, Immunotherapy +17